Indian Journal of Rheumatology
Volume 6, Issue 2 , Pages 68-75, June 2011

Indian rheumatology association guidelines for management of glucocorticoid-induced osteoporosis

  • Venkataraman Krishnamurthy

      Affiliations

    • Consultant Rheumatology, Apollo Speciality Hospital, Chennai & Meenakshi Multispecialty Hospital, Chennai
    • Corresponding Author InformationCorrespondence: Venkataraman Krishnamurthy
    • ,
  • Aman Sharma

      Affiliations

    • Assistant Professor (Rheumatology), Department of Internal Medicine, PGIMER, Chandigarh
    • ,
  • Amita Aggarwal

      Affiliations

    • Additional Professor, Department of Clinical Immunology, SGPGI, Lucknow
    • ,
  • Uma Kumar

      Affiliations

    • Additional Professor of Medicine Head, Clinical Immunology & Rheumatology, AIIMS, New Delhi
    • ,
  • Sanjiv Amin

      Affiliations

    • Consultant Rheumatology, Mumbai
    • ,
  • Uppuluri Ramakrishna Rao

      Affiliations

    • Director & Consultant Rheumatology, Sri Deepti Rheumatology Centre, Hyderabad
    • ,
  • Gumdal Narsimulu

      Affiliations

    • Professor & Head, Department of Rheumatology, Nizam's Institute of Medical Sciences, Hyderabad
    • ,
  • Rohini Handa

      Affiliations

    • Senior Consultant Rheumatologist, Apollo Indraprastha Hospitals, New Delhi
    • ,
  • Ambrish Mithal

      Affiliations

    • Chairman & HOD, Division of Endocrinology and Diabetes, Medanta, the Medicity, Mumbai
    • ,
  • Shashank Joshi

      Affiliations

    • Senior Consultant (Endocrinologist), Lilavati Hospital and Research Center, Mumbai

Article Outline

No abstract is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. van Staa TP , Leufkens HGM , Abenhaim L , Zhang B , Cooper C . Use of oral corticosteroids and risk of fractures . J Bone Miner Res . 2000;15:993–1000
  2. Laan RFJM , van Riel PLCM , van de Putte LBA , van Erning LJTO , van't Hof MA , Lemmens JAM . Low-dose prednisolone induces rapid reversible axial bone loss in patients with rheumatoid arthritis . Ann Intern Med . 1993;119:963–968
  3. O'Brien CA , Jia D , Plotkin LI , Bellido T , Powers CC , Stewart SA , et al.   Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength . Endocrinology . 2004;145:1835–1841
  4. Cooper C , Coupland C , Mitchell M . Rheumatoid arthritis, corticosteroid therapy and hip fracture . Ann Rheum Dis . 1995;54:49–52
  5. van Rossum EF , Lamberts SW . Polymorphism in the gluco-corticosteroid receptor gene and their association with metabolic parameters and body composition . Recent Prog Horm Res . 2004;59:333–357
  6. Cummings SR , Melton LJ . Epidemiology and outcomes of osteoporotic fractures . Lancet . 2002;359:1761–1767
  7. Kannus P , Sievanen H , Palvanen M , et al.   Prevention of falls and consequent injuries in elderly people . Lancet . 2005;366:1885–1893
  8. Bischoff HA , Stahelin HB , Dick  , et al.   Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial . J Bone Min Res . 2003;18:343–351
  9. Fielding RA . The role of progressive resistance training and nutrition in the preservation of lean body mass in the elderly . J Am Coll Nutrition . 1995;14:587–594
  10. Duncan CS , Blimkie CJ , Cowell CT , et al.   Bone mineral density in adolescent female athletes: relationship to exercise type and muscle strength . Med Sci Sports Exercise . 2002;34:286–294
  11. Ziegler R , Kasperk C . Glucocorticoid-induced osteoporosis: prevention and treatment . Steroids . 1998;63:344–348
  12. Boonen S , Lips P , Bouillon R , et al.   Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative meta-analysis of randomized controlled trials . J Clinic Endo Metabol . 2007;92:1415–1423
  13. Zhu K , Devine A , Dick IM , et al.   Effects of calcium and vitamin D supplementation on hip bone mineral density and calcium-related analytes in elderly ambulatory Australian women: a 5-year randomised controlled trial. Calcium and vitamin D prevents hip bone loss . J Clini Endo Metabol . 2008;93:743–749
  14. Boonen S , Bischoff-Ferrari A , Cooper C , et al.   Addressing the músculo skeletal components of fracture risk with calcium and vitamin D: a review of the evidence . Calcified Tissue International . 2006;78:257–270
  15. Dawson-Hughes B , Harris SS , Krall EA , et al.   Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women . Am J Clin Nutrition . 2000;72:745–750
  16. Boonen S , Dejaeger E , Vanderschueren D , et al.   Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective . Best Prac Res Clin Endocrinol Metabol . 2008;22:765–785
  17. Curhan GC , Willett WC , Rimm EB , et al.   A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones . N Engl J Med . 1993;328:833–838
  18. Bolland J , Avenell A , Baron J , et al.   Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis . BMJ . 2010;341:c3691
  19. Ziegler R , Kasperk C . Glucocorticoid-induced osteoporosis: prevention and treatment . Steroids . 1998;63:344–348
  20. Saigal R , Mathur Y , Prashant RK , et al.   Glucocorticoid-induced osteoporosis . Indian J Rheumatol . 2006;1:20–25
  21. Dickiel LJ , Church LD , Coulthard LR , et al.   Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes . Rheumatology . 2010;49:1466–1471
  22. Campbell IA , Douglas JG , Francis RM , Prescott RJ , Reid DM , On behalf of the Research Committee of the British Thoracic Society  . Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled Glucocorticoids . Thorax . 2004;59:761–768
  23. Ringe JD , Dorst A , Faber H , Ibach K , Preuss J . Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis . Rheumatology . 2003;42:743–749
  24. Reid DM , et al.   Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomized controlled trial . Lancet . 2009;373:1253–1263
  25. Cranney A , Welch Y , Adachi JD , Homik J , Shea B , Suarez-Almazor ME , et al.   Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis . Cochrane Database Syst Rev . 2000;CDOO1983
  26. Saag KG , Shane E , Boonen S , Marin F , Donley DW , Taylor KA , et al.   Teriperatide or alendronate in glucocorticoid-induced osteoporosis . N Engl J Med . 2007;357:2028–2039
  27. Reid IR , Wattie DJ , Evans MC , Stapleton JP . Testosterone therapy in glucocorticoid-treated men . Arch Intern Med . 1996;156:1173–1177
  28. Rudge S , Hailwood S , Home A , Lucas J , Wu F , Cundy T . Effects of once weekly oral alendronate on bone in children on glucocortcoid treatment . Rheumatology . 2005;44:813–818
  29. Grossman JM , Gordon R , Ranganath VK , Deal C , Caplan L , Chen W , et al.   American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid induced osteoporosis . Arthritis Care Res . 2010;62:1515–1526

 Endorsed by: Endocrine Society of India and Indian Society for Bone & Mineral Research

PII: S0973-3698(11)60060-5

doi:10.1016/S0973-3698(11)60060-5

Refers to erratum:

  • Corrigendum

    Indian Journal of Rheumatology September 2011 (Vol. 6, Issue 3, Page 163)

Indian Journal of Rheumatology
Volume 6, Issue 2 , Pages 68-75, June 2011

Article Tools